Intrasense (PA:ALINS) — Market Cap & Net Worth
Market Cap & Net Worth: Intrasense (ALINS)
Intrasense (PA:ALINS) has a market capitalization of $11.37 Million (€9.73 Million) as of September 17, 2026. Listed on the PA stock exchange, this France-based company holds position #26835 globally and #453 in its home market, demonstrating a -11.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intrasense's stock price €0.24 by its total outstanding shares 52662004 (52.66 Million). Also see ALINS asset base for a full breakdown of the balance sheet.
Intrasense Market Cap History: 2015 to 2026
Intrasense's market capitalization history from 2015 to 2026. Data shows change from $74.57 Million to $14.53 Million (-15.60% CAGR). Also see Intrasense (ALINS) cash conversion ratio for how efficiently the company converts equity into cash flow.
Intrasense Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intrasense's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Intrasense for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.76x
Intrasense's market cap is 4.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $35.80 Million | $3.69 Million | -$1.77 Million | 9.70x | N/A |
| 2017 | $30.43 Million | $2.99 Million | -$2.10 Million | 10.17x | N/A |
| 2018 | $11.68 Million | $3.77 Million | -$1.51 Million | 3.10x | N/A |
| 2019 | $14.32 Million | $3.32 Million | -$912.00K | 4.32x | N/A |
| 2020 | $61.45 Million | $3.44 Million | -$704.00K | 17.86x | N/A |
| 2021 | $32.32 Million | $4.19 Million | -$1.20 Million | 7.72x | N/A |
| 2022 | $19.95 Million | $3.79 Million | -$3.42 Million | 5.26x | N/A |
| 2023 | $22.16 Million | $3.31 Million | -$3.58 Million | 6.71x | N/A |
| 2024 | $14.22 Million | $2.25 Million | -$5.66 Million | 6.33x | N/A |
| 2025 | $14.10 Million | $2.96 Million | -$10.81 Million | 4.76x | N/A |
Competitor Companies of ALINS by Market Capitalization
Companies near Intrasense in the global market cap rankings as of September 17, 2026. Review Intrasense (ALINS) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Intrasense by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #738 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1902 globally with a market cap of $12.23 Billion USD ( AU$17.28 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2133 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #738 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $266.62 |
| #1902 | Pro Medicus Ltd | AU:PME | $12.23 Billion | AU$165.45 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $68.85 |
| #2133 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.84 |
Intrasense Historical Marketcap From 2015 to 2026
Between 2015 and today, Intrasense's market cap moved from $74.57 Million to $ 14.53 Million, with a yearly change of -15.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €14.53 Million | +3.06% |
| 2025 | €14.10 Million | -0.87% |
| 2024 | €14.22 Million | -35.83% |
| 2023 | €22.16 Million | +11.11% |
| 2022 | €19.95 Million | -38.29% |
| 2021 | €32.32 Million | -47.40% |
| 2020 | €61.45 Million | +329.11% |
| 2019 | €14.32 Million | +22.61% |
| 2018 | €11.68 Million | -61.61% |
| 2017 | €30.43 Million | -15.00% |
| 2016 | €35.80 Million | -52.00% |
| 2015 | €74.57 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Intrasense was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.37 Million USD |
| MoneyControl | $11.37 Million USD |
| MarketWatch | $11.37 Million USD |
| marketcap.company | $11.37 Million USD |
| Reuters | $11.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Intrasense
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that… Read more